TY - JOUR PY - 1995 DA - 1995// TI - Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group JO - Lancet. VL - 345 UR - https://doi.org/10.1016/S0140-6736(95)92534-1 DO - 10.1016/S0140-6736(95)92534-1 ID - ref1 ER - TY - JOUR AU - Tashkin, D. P. AU - Roth, M. D. AU - Clements, P. J. AU - Furst, D. E. AU - Khanna, D. AU - Kleerup, E. C. PY - 2016 DA - 2016// TI - Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial JO - Lancet Respir Med VL - 4 UR - https://doi.org/10.1016/S2213-2600(16)30152-7 DO - 10.1016/S2213-2600(16)30152-7 ID - Tashkin2016 ER - TY - JOUR AU - Volkmann, E. R. AU - Tashkin, D. P. AU - Li, N. AU - Roth, M. D. AU - Khanna, D. AU - Hoffmann-Vold, A. M. PY - 2017 DA - 2017// TI - Mycophenolate mofetil versus placebo for systemic sclerosis-related interstitial lung disease: an analysis of Scleroderma Lung Studies I and II JO - Arthritis Rheumatol VL - 69 UR - https://doi.org/10.1002/art.40114 DO - 10.1002/art.40114 ID - Volkmann2017 ER - TY - JOUR AU - Herrick, A. L. AU - Pan, X. AU - Peytrignet, S. AU - Lunt, M. AU - Hesselstrand, R. AU - Mouthon, L. PY - 2017 DA - 2017// TI - Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS) JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-210503 DO - 10.1136/annrheumdis-2016-210503 ID - Herrick2017 ER - TY - JOUR AU - Fernández-Codina, A. AU - Walker, K. M. AU - Pope, J. E. PY - 2018 DA - 2018// TI - Treatment algorithms for systemic sclerosis according to experts JO - Arthritis Rheumatol. VL - 70 UR - https://doi.org/10.1002/art.40560 DO - 10.1002/art.40560 ID - Fernández-Codina2018 ER - TY - JOUR AU - Gelder, T. AU - Meur, Y. AU - Shaw, L. M. AU - Oellerich, M. AU - DeNofrio, D. AU - Holt, C. PY - 2006 DA - 2006// TI - Therapeutic drug monitoring of mycophenolate mofetil in transplantation JO - Ther Drug Monit VL - 28 UR - https://doi.org/10.1097/01.ftd.0000199358.80013.bd DO - 10.1097/01.ftd.0000199358.80013.bd ID - Gelder2006 ER - TY - JOUR AU - Benjanuwattra, J. AU - Pruksakorn, D. AU - Koonrungsesomboon, N. PY - 2020 DA - 2020// TI - Mycophenolic acid and its pharmacokinetic drug-drug interactions in humans: review of the evidence and clinical implications JO - J Clin Pharmacol VL - 60 UR - https://doi.org/10.1002/jcph.1565 DO - 10.1002/jcph.1565 ID - Benjanuwattra2020 ER - TY - JOUR AU - Winter, B. C. AU - Neumann, I. AU - Hest, R. M. AU - Gelder, T. AU - Mathot, R. A. PY - 2009 DA - 2009// TI - Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease JO - Ther Drug Monit VL - 31 UR - https://doi.org/10.1097/FTD.0b013e3181a23f1a DO - 10.1097/FTD.0b013e3181a23f1a ID - Winter2009 ER - TY - JOUR AU - Zahr, N. AU - Arnaud, L. AU - Marquet, P. AU - Haroche, J. AU - Costedoat-Chalumeau, N. AU - Hulot, J. S. PY - 2010 DA - 2010// TI - Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil JO - Arthritis Rheum VL - 62 ID - Zahr2010 ER - TY - JOUR AU - Wakahashi, K. AU - Yamamori, M. AU - Minagawa, K. AU - Ishii, S. AU - Nishikawa, S. AU - Shimoyama, M. PY - 2011 DA - 2011// TI - Pharmacokinetics-based optimal dose prediction of donor source-dependent response to mycophenolate mofetil in unrelated hematopoietic cell transplantation JO - Int J Hematol VL - 94 UR - https://doi.org/10.1007/s12185-011-0888-6 DO - 10.1007/s12185-011-0888-6 ID - Wakahashi2011 ER - TY - JOUR AU - Andréasson, K. AU - Scheja, A. AU - Saxne, T. AU - Ohlsson, B. AU - Hesselstrand, R. PY - 2011 DA - 2011// TI - Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis JO - J Intern Med VL - 270 UR - https://doi.org/10.1111/j.1365-2796.2010.02340.x DO - 10.1111/j.1365-2796.2010.02340.x ID - Andréasson2011 ER - TY - JOUR AU - Andréasson, K. AU - Alrawi, Z. AU - Persson, A. AU - Jönsson, G. AU - Marsal, J. PY - 2016 DA - 2016// TI - Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease JO - Arthritis Res Ther VL - 18 UR - https://doi.org/10.1186/s13075-016-1182-z DO - 10.1186/s13075-016-1182-z ID - Andréasson2016 ER - TY - JOUR AU - Volkmann, E. R. AU - Chang, Y. L. AU - Barroso, N. AU - Furst, D. E. AU - Clements, P. J. AU - Gorn, A. H. PY - 2016 DA - 2016// TI - Association of systemic sclerosis with a unique colonic microbial consortium JO - Arthritis Rheumatol. VL - 68 UR - https://doi.org/10.1002/art.39572 DO - 10.1002/art.39572 ID - Volkmann2016 ER - TY - JOUR AU - Patrone, V. AU - Puglisi, E. AU - Cardinali, M. AU - Schnitzler, T. S. AU - Svegliati, S. AU - Festa, A. PY - 2017 DA - 2017// TI - Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-14889-6 DO - 10.1038/s41598-017-14889-6 ID - Patrone2017 ER - TY - JOUR AU - Richard, N. AU - Hudson, M. AU - Wang, M. AU - Gyger, G. AU - Proudman, S. AU - Stevens, W. PY - 2019 DA - 2019// TI - Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality JO - Rheumatology (Oxford) VL - 58 UR - https://doi.org/10.1093/rheumatology/key350 DO - 10.1093/rheumatology/key350 ID - Richard2019 ER - TY - JOUR AU - Ammitzbøll, T. AU - Hendel, L. AU - Kreuzig, F. AU - Asboe-Hansen, G. PY - 1987 DA - 1987// TI - Bioavailability of D-penicillamine in relation to gastrointestinal involvement of generalized scleroderma JO - Scand J Rheumatol VL - 16 UR - https://doi.org/10.3109/03009748709102917 DO - 10.3109/03009748709102917 ID - Ammitzbøll1987 ER - TY - JOUR AU - Mendoza, F. A. AU - Lee-Ching, C. AU - Jimenez, S. A. PY - 2020 DA - 2020// TI - Recurrence of progressive skin involvement following discontinuation or dose reduction of mycophenolate mofetil treatment in patients with diffuse systemic sclerosis JO - Semin Arthritis Rheum VL - 50 UR - https://doi.org/10.1016/j.semarthrit.2019.06.012 DO - 10.1016/j.semarthrit.2019.06.012 ID - Mendoza2020 ER - TY - JOUR AU - Roos, N. AU - Poulalhon, N. AU - Farge, D. AU - Madelaine, I. AU - Mauviel, A. AU - Verrecchia, F. PY - 2007 DA - 2007// TI - In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil JO - J Pharmacol Exp Ther VL - 321 UR - https://doi.org/10.1124/jpet.106.117051 DO - 10.1124/jpet.106.117051 ID - Roos2007 ER - TY - JOUR AU - Hoogen, F. AU - Khanna, D. AU - Fransen, J. AU - Johnson, S. R. AU - Baron, M. AU - Tyndall, A. PY - 2013 DA - 2013// TI - 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative JO - Arthritis Rheum VL - 65 UR - https://doi.org/10.1002/art.38098 DO - 10.1002/art.38098 ID - Hoogen2013 ER - TY - JOUR AU - Sandqvist, A. M. AU - Henrohn, D. AU - Schneede, J. AU - Hedeland, M. AU - Egeröd, H. C. AU - Bondesson, U. G. PY - 2013 DA - 2013// TI - High inter-individual variability of vardenafil pharmacokinetics in patients with pulmonary hypertension JO - Eur J Clin Pharmacol VL - 69 UR - https://doi.org/10.1007/s00228-012-1323-5 DO - 10.1007/s00228-012-1323-5 ID - Sandqvist2013 ER - TY - JOUR AU - Walker, U. A. AU - Tyndall, A. AU - Czirják, L. AU - Farge-Bancel, D. AU - Kowal-Bielecka, O. AU - Müller-Ladner, U. PY - 2007 DA - 2007// TI - Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.062901 DO - 10.1136/ard.2006.062901 ID - Walker2007 ER - TY - JOUR AU - Grubb, A. PY - 2010 DA - 2010// TI - Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check JO - Scand J Clin Lab Invest VL - 70 UR - https://doi.org/10.3109/00365511003642535 DO - 10.3109/00365511003642535 ID - Grubb2010 ER - TY - JOUR AU - Khanna, D. AU - Hays, R. D. AU - Maranian, P. AU - Seibold, J. R. AU - Impens, A. AU - Mayes, M. D. PY - 2009 DA - 2009// TI - Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument JO - Arthritis Rheum VL - 61 UR - https://doi.org/10.1002/art.24730 DO - 10.1002/art.24730 ID - Khanna2009 ER - TY - JOUR AU - Valentini, G. AU - Iudici, M. AU - Walker, U. A. AU - Jaeger, V. K. AU - Baron, M. AU - Carreira, P. PY - 2017 DA - 2017// TI - The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-209768 DO - 10.1136/annrheumdis-2016-209768 ID - Valentini2017 ER - TY - JOUR AU - Baron, M. AU - Hudson, M. AU - Steele, R. PY - 2009 DA - 2009// TI - Malnutrition is common in systemic sclerosis: results from the Canadian Scleroderma Research Group database JO - J Rheumatol VL - 36 UR - https://doi.org/10.3899/jrheum.090694 DO - 10.3899/jrheum.090694 ID - Baron2009 ER - TY - JOUR AU - Luszczyńska, P. AU - Pawiński, T. AU - Kunicki, P. K. AU - Durlik, M. AU - Augustyniak-Bartosik, H. AU - Hurkacz, M. PY - 2019 DA - 2019// TI - Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoring JO - Eur J Clin Pharmacol VL - 75 UR - https://doi.org/10.1007/s00228-018-2599-x DO - 10.1007/s00228-018-2599-x ID - Luszczyńska2019 ER - TY - JOUR AU - Chaigne, B. AU - Gatault, P. AU - Darrouzain, F. AU - Barbet, C. AU - Degenne, D. AU - François, M. PY - 2014 DA - 2014// TI - Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study JO - Clin Exp Immunol VL - 176 UR - https://doi.org/10.1111/cei.12246 DO - 10.1111/cei.12246 ID - Chaigne2014 ER - TY - JOUR AU - Veličković-Radovanović, R. M. AU - Janković, S. M. AU - Milovanović, J. R. AU - Catić-Dordević, A. K. AU - Spasić, A. S. AU - Stefanović, N. Z. PY - 2015 DA - 2015// TI - Variability of mycophenolic acid elimination in the renal transplant recipients – population pharmacokinetic approach JO - Ren Fail VL - 37 UR - https://doi.org/10.3109/0886022X.2015.1010442 DO - 10.3109/0886022X.2015.1010442 ID - Veličković-Radovanović2015 ER - TY - JOUR AU - Nihtyanova, S. I. AU - Schreiber, B. E. AU - Ong, V. H. AU - Rosenberg, D. AU - Moinzadeh, P. AU - Coghlan, J. G. PY - 2014 DA - 2014// TI - Prediction of pulmonary complications and long-term survival in systemic sclerosis JO - Arthritis Rheumatol. VL - 66 UR - https://doi.org/10.1002/art.38390 DO - 10.1002/art.38390 ID - Nihtyanova2014 ER - TY - JOUR AU - Schaier, M. AU - Scholl, C. AU - Scharpf, D. AU - Hug, F. AU - Bönisch-Schmidt, S. AU - Dikow, R. PY - 2010 DA - 2010// TI - Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil JO - Rheumatology (Oxford) VL - 49 UR - https://doi.org/10.1093/rheumatology/keq238 DO - 10.1093/rheumatology/keq238 ID - Schaier2010 ER - TY - JOUR AU - Morath, C. AU - Schwenger, V. AU - Beimler, J. AU - Mehrabi, A. AU - Schmidt, J. AU - Zeier, M. PY - 2006 DA - 2006// TI - Antifibrotic actions of mycophenolic acid JO - Clin Transpl VL - 20 UR - https://doi.org/10.1111/j.1399-0012.2006.00597.x DO - 10.1111/j.1399-0012.2006.00597.x ID - Morath2006 ER -